Fundraising Fox

Healthtech Late Stage Investors & VC Firms

847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.

Altara Ventures
SingaporeSeed–Late Stage$3M – $5M
13 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
7 people
NovaCapital
Seed–Late Stage
9 people
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
2 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
VestedWorld
ChicagoSeed–Late Stage$500K – $1M
7 people
GroundForce Capital
VeniceSeed–Late Stage$10M – $35M
9 people
Minerva Growth Partners
TokyoGrowth–Late Stage$6.7M – $20M
14 people
Pemba Capital Partners Pty Ltd.
SydneyGrowth–Late Stage$6.6M – $19.8M
7 people
Wittington Ventures
TorontoSeed–Late Stage
13 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
OWW Capital Partners Pte. Ltd.
SingaporeSeed–Late Stage$500K – $10M
9 people
Pharos Capital Group
DallasGrowth–Late Stage$25M – $50M
18 people
Phatisa
BambouGrowth–Late Stage
15 people
Prysm Capital
San FranciscoGrowth–Late Stage
15 people
Puhua Capital
HangzhouPre-Seed–Late Stage$1.4M – $112M
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Unison Capital
TokyoGrowth–Late Stage
5 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
13 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.